Administration of EVs from human liver stem cells to SCID mice with diet-induced NASH resulted in decreased serum ALT, hepatic fibrosis and expression of fibrosis- and inflammation-related genes [285]. The gene discussed is GPT; the disease is Hepatic fibrosis.